Cell-Assisted Lipotransfer Shows Potential in Facial and Breast Applications, Review Finds

Cell-assisted lipotransfer (CAL) continues to evolve as an adjunct to conventional fat grafting, with a recent review in Annali Italiani di Chirurgia summarizing current evidence for its use in facial and breast procedures. CAL involves enrichment of autologous fat grafts with regenerative cellular components, most commonly stromal vascular fraction (SVF) or adipose-derived stem cells (ADSCs), with the goal of improving graft viability and clinical outcomes.

The review describes proposed mechanisms underlying CAL, including enhanced early angiogenesis, reduced graft resorption, and improved long-term volume retention. These effects are attributed to the regenerative and paracrine activity of SVF and ADSCs, as well as adjunctive use of platelet-rich plasma (PRP), which may further support tissue remodeling and skin quality.

Clinical applications highlighted include facial rejuvenation and contour correction, as well as breast reconstruction and augmentation. Across these indications, CAL is presented as a strategy to address variability in fat graft survival, a longstanding limitation of traditional lipotransfer techniques. However, the authors note that reported outcomes remain heterogeneous, reflecting differences in harvesting, processing, and reinjection techniques.

Importantly, the review underscores several unresolved challenges. There is currently no consensus on standardized processing protocols or optimal cell concentrations, and long-term safety data remain limited. Regulatory considerations also vary by region, particularly regarding the manipulation and use of cellular components such as ADSCs.

“Overall, the aim is to provide a foundation for developing standardized clinical protocols for CAL,” the authors wrote. “This approach is intended to enhance the survival and structural stability of conventional fat grafts, thereby improving outcomes in soft-tissue augmentation and regeneration.”